Abstract
Simvastatin has been shown to restore endothelial function in children with familial hypercolesterolemia after 28 weeks of treatment. The aim of this study was to evaluate 1-month simvastatin treatment effect on endothelial function in hypercholesterolemic children and adolescents. Eighteen hypercholesterolemic patients (HC group) and 18 healthy controls, aged 6–18 years, were studied with medical history, physical examination, full lipid profile, serum apolipoprotein B (apo B), fibrinogen, hepatic transaminases, and creatine kinase concentrations. Flow-mediated dilatation (FMD) was performed by high-resolution ultrasound of the brachial artery. The HC group received simvastatin 10 mg/day for 1 month. Arterial diameter was measured by two experienced sonographers who were unaware of subjects’ conditions. At baseline, FMD was impaired in the HC group (mean, 5.27 ± 4.67%) compared to controls (mean, 15.05 ± 5.97%) (p < 0.001). After treatment, we observed a significant reduction in total cholesterol (TC) (29%), low-density lipoprotein cholesterol (LDL-C); (37%), apo B concentrations (36%) and FMD restoration (mean, 12.94 ± 7.66%), with an absolute increase of 7.66 ± 8.58 (p = 0.001). These results show that children and adolescents with hypercholesterolemia present endothelial dysfunction, and simvastatin, in addition to significantly reducing TC, LDL-C, and apo B concentrations, restores endothelial function with 1-month treatment.
Similar content being viewed by others
References
Aggoun Y, Bonnet D, Sidi D, et al. (2000) Arterial mechanical changes in children with familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 20:2070–2075
Alonso R, Mata P, De Andres R, et al. (2001) Sustained long-term improvement of arterial endothelial function in heterozygous familial hypercholesterolemia patients treated with simvastatin. Atherosclerosis 157:423–429
Berenson GS, Srinivasan SR, Bao W, et al. (1998) Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med 338:1650–1656
Celermajer DS, Sorensen KE, Gooch VM, et al. (1992) Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340:1111–1115
De Caterina R, Lenzi S (1998) The role of LDL in the origin and progression of atherosclerosis: pathobiological concepts on the origin and development of atherosclerotic lesions and the role of the endothelium. G Ital Cardiol 28:158–167
de Jongh S, Lilien MR, Bakker HD, et al. (2002) Family history of cardiovascular events and endothelial dysfunction in children with familial hypercholesterolemia. Atherosclerosis 163:193–197
de Jongh S, Lilien MR, op’t Roodt J, et al. (2002) Early statin therapy restores endothelial function in children with familial hypercholesterolemia. J Am Coll Cardiol 40:2117–2121
de Jongh S, Ose L, Szamosi T, et al. (2002) Simvastatin in Children Study Group. Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized, double-blind, placebo-controlled trial with simvastatin. Circulation 106:2231–2237
Gerber ZRS, Zielinsky P (1997) Risk factors of atherosclerosis in children. An epidemiologic study. Arq Bras Cardiol 69:231–236
Gordon T, Kannel WB, Castelli WP, Dawber TR (1981) Lipoproteins, cardiovascular disease, and death. The Framingham study. Arch Intern Med 141:1128–1131
Holman RL, McGill HC Jr, Strong JP, Geer JC (1958) The natural history of atherosclerosis: the early aortic lesions as seen in New Orleans in the middle of the 20th century. Am J Pathol 34:209–235
Jarvisalo MJ, Lehtimaki T, Raitakari OT (2004) Determinants of arterial nitrate-mediated dilatation in children: role of oxidized low-density lipoprotein, endothelial function, and carotid intima-media thickness. Circulation 109:2885–2889
Joannides R, Haefeli WE, Linder L, et al. (1995) Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation 91:1314–1319
Kadikoylu G, Yukselen V, Yavasoglu I, Bolaman Z (2003) Hemostatic effects of atorvastatin versus simvastatin. Ann Pharmacother 37:478–484
Laufs U, La Fata V, Plutzky J, Liao JK (1998) Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 97:1129–1135
Leeson CP, Whincup PH, Cook DG, et al. (2000) Cholesterol and arterial distensibility in the first decade of life: a population-based study. Circulation 101:1533–1538
Makris TK, Hatzizacharias AN, Krespi PG, et al. (2003) Markers of risk in young offspring with paternal history of myocardial infarction. Int J Cardiol 89:287–293
Martinez-Gonzalez J, Llorente-Cortes V, Badimon L (2001) Cellular and molecular biology of atherosclerotic lesions. Rev Esp Cardiol 54:218–231
McCrindle BW, Ose L, Marais AD (2003) Efficacy and safety of atorvastatin in children and adolescents with familial hypercholesterolemia or severe hyperlipidemia: a multicenter, randomized, placebo-controlled trial. J Pediatr 143: 74–80
McGill HC Jr, McMahan CA, Herderick EE, et al. (2000) Origin of atherosclerosis in childhood and adolescence. Am J Clin Nutr 72(5 Suppl):1307S–1315S
Newman WP 3rd, Freedman DS, Voors AW, et al. (1986) Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis. The Bogalusa Heart Study. N Engl J Med 314:138–144
O’Driscoll G, Green D, Taylor RR (1997) Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month. Circulation 95:1126–1131
Reddy KG, Nair RN, Sheehan HM, Hodgson JM (1994) Evidence that selective endothelial dysfunction may occur in the absence of angiographic or ultrasound atherosclerosis in patients with risk factors for atherosclerosis. J Am Coll Cardiol 23:833–843
Reinhart WH (2003) Fibrinogen—marker or mediator of vascular disease? Vasc Med 8:211–216
Scandinavian Simvastatin Survival Group (2000) Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344:1383–1389
Singh TP, Groehn H, Kazmers A (2003) Vascular function and carotid intimal-medial thickness in children with insulin-dependent diabetes mellitus. J Am Coll Cardiol 41:661–665
Wiegman A, de Groot E, Hutten BA, et al. (2004) Arterial intima-media thickness in children heterozygous for familial hypercholesterolaemia. Lancet 363:369–370
Wiegman A, Hutten BA, de Groot E, et al. (2004) Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial. J Am Med Assoc 292:331–337
World Health Organization (1999) Report of a Second WHO Consultation. Geneva 1-23. WHO/HGN/FH/CONS/99.2
Zeiher AM, Drexler H, Wollschlager H, Just H (1991) Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation 83:391–401
Acknowledgments
We thank the children who participated in this study as well as their parents who trusted our team.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ferreira, W.P., Bertolami, M.C., Santos, S.N. et al. One-Month Therapy with Simvastatin Restores Endothelial Function in Hypercholesterolemic Children and Adolescents. Pediatr Cardiol 28, 8–13 (2007). https://doi.org/10.1007/s00246-005-1304-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00246-005-1304-x